Abstract: Inoculating systems/devices, methods for inoculating a target, and coating methods are disclosed. An example inoculating system may include an inoculating member having a transfer region and a handle region. A pre-determined quantity of viable microorganisms may be disposed on the transfer region. The inoculating member may be configured to transfer the pre-determined quantity of viable microorganisms to a target during an inoculation operation without having to rehydrate the pre-determined quantity of viable microorganisms prior to the inoculating operation.

Abstract: This present invention relates to a stabilizer fin which is designed to act as a rudder system for a towable floatation device. The stabilizer fin can be mounted to any conventional pull behind floatable device to keep the device tracking straighter as it is pulled through the water. The stabilizer fin assembly comprises a mounting plate that is moulded to fit to the shape of the rear of the floatable device, and a fin designed to be attached to the mounting plate. The fin pivots freely between vertical up and down positions. The fin is counterweighted in order for the fin to fall freely into the lowered or down position while in the water. The stabilizer fin ensures that the floatable device does not create unnecessary drag and eases the paddling process for a watercraft operator towing the floatable device.

Abstract: Inoculating systems/devices, methods for inoculating a target, and coating methods are disclosed. An example inoculating system may include an inoculating member having a transfer region and a handle region. A pre-determined quantity of viable microorganisms may be disposed on the transfer region. The inoculating member may be configured to transfer the pre-determined quantity of viable microorganisms to a target during an inoculation operation without having to rehydrate the pre-determined quantity of viable microorganisms prior to the inoculating operation.

Abstract: Microbiota restoration therapy (MRT) compositions (e.g., oral MRT compositions) and methods for manufacturing MRT compositions are disclosed. An example method for manufacturing an MRT composition may include collecting a stool sample, purifying the stool sample to form a purified sample, stabilizing the purified sample to form a stabilized sample, converting the stabilized sample to a solid, adding one or more additives and/or excipients to the solid to form a treatment composition, and encapsulating the treatment composition.

Abstract: An ultraviolet (UV) light test device is suitable for ascertaining the efficacy of a germicidal UV light source. The UV light test device includes a population of viable microbial material having a residual water content of less than five percent. The population of viable microbial material is encapsulated in a container. At least a portion of the container is formed of a UV light transmissible material such that UV light from the germicidal UV light source is able to contact the population of viable microbial material.

Abstract: Microbiota restoration therapy (MRT) compositions (e.g., oral MRT compositions) and methods for manufacturing MRT compositions are disclosed. An example method for manufacturing an MRT composition may include collecting a stool sample, purifying the stool sample to form a purified sample, stabilizing the purified sample to form a stabilized sample, converting the stabilized sample to a solid, adding one or more additives and/or excipients to the solid to form a treatment composition, and encapsulating the treatment composition.

Abstract: An actuator assembly system array. The actuator assembly system array comprises a plurality of separate actuator assembly systems arranged in a row, with each actuator assembly system of the plurality of separate actuator assembly systems comprising: an array of one or more solar panels; a plurality of fluidic actuator assemblies; and a plurality of posts respectively coupled to and extending from the plurality of fluidic actuator assemblies. The actuator assembly system array further includes a fluidic control system comprising a plurality of fluid lines extending between and fluidically coupling the plurality of separate actuator assembly systems in series.

Abstract: An actuator assembly that includes an angled bottom plate having an opposing first side face and second side face; a first set of one or more inflatable actuators engaging the first side face of the angled bottom plate; and a second set of one or more inflatable actuators engaging the second side face of the angled bottom plate. The first and second sets of inflatable actuators are configured to be separately fluidically inflated.

Abstract: Microbiota restoration therapy (MRT) compositions (e.g., oral MRT compositions) and methods for manufacturing MRT compositions are disclosed. An example method for manufacturing an MRT composition may include collecting a stool sample, purifying the stool sample to form a purified sample, stabilizing the purified sample to form a stabilized sample, converting the stabilized sample to a solid, adding one or more additives and/or excipients to the solid to form a treatment composition, and encapsulating the treatment composition.

Abstract: Microbiota restoration therapy (MRT) compositions (e.g., oral MRT compositions) and methods for manufacturing MRT compositions are disclosed. An example method for manufacturing an MRT composition may include collecting a stool sample, purifying the stool sample to form a purified sample, stabilizing the purified sample to form a stabilized sample, converting the stabilized sample to a solid, adding one or more additives and/or excipients to the solid to form a treatment composition, and encapsulating the treatment composition.

Abstract: Methods of evaluating the antimicrobial efficacy of a hard surface disinfectant or sanitizer and test articles are disclosed. An example method may include removing a preserved antimicrobial test article from a sealed container. The preserved antimicrobial test article may comprise a non-water soluble substrate and a thin microbial layer attached to the substrate comprising viable microbial material, a stabilizing mixture, and a residual water content of less than 5.0%. The method may also include contacting the preserved antimicrobial test article with a predetermined amount of the test substance without rehydrating the preserved microbial article and without detaching the layer comprising the viable microbial material from the substrate prior to contact with the test substance.

Abstract: Microbiota restoration therapy (MRT) compositions (e.g., oral MRT compositions) and methods for manufacturing MRT compositions are disclosed. An example method for manufacturing an MRT composition may include collecting a stool sample, purifying the stool sample to form a purified sample, stabilizing the purified sample to form a stabilized sample, converting the stabilized sample to a solid, adding one or more additives and/or excipients to the solid to form a treatment composition, and encapsulating the treatment composition.

Abstract: Inoculating systems/devices, methods for inoculating a target, and coating methods are disclosed. An example inoculating system may include an inoculating member having a transfer region and a handle region. A pre-determined quantity of viable microorganisms may be disposed on the transfer region. The inoculating member may be configured to transfer the pre-determined quantity of viable microorganisms to a target during an inoculation operation without having to rehydrate the pre-determined quantity of viable microorganisms prior to the inoculating operation.

Abstract: Inoculating systems/devices, methods for inoculating a target, and coating methods are disclosed. An example inoculating system may include an inoculating member having a transfer region and a handle region. A pre-determined quantity of viable microorganisms may be disposed on the transfer region. The inoculating member may be configured to transfer the pre-determined quantity of viable microorganisms to a target during an inoculation operation without having to rehydrate the pre-determined quantity of viable microorganisms prior to the inoculating operation.

Abstract: This present invention relates to a stabilizer fin which is designed to act as a rudder system for a towable floatation device. The stabilizer fin can be mounted to any conventional pull behind floatable device to keep the device tracking straighter as it is pulled through the water. The stabilizer fin assembly comprises a mounting plate that is moulded to fit to the shape of the rear of the floatable device, and a fin designed to be attached to the mounting plate. The fin pivots freely between vertical up and down positions. The fin is counterweighted in order for the fin to fall freely into the lowered or down position while in the water. The stabilizer fin ensures that the floatable device does not create unnecessary drag and eases the paddling process for a watercraft operator towing the floatable device.

Abstract: Inoculating systems/devices, methods for inoculating a target, and coating methods are disclosed. An example inoculating system may include an inoculating member having a transfer region and a handle region. A pre-determined quantity of viable microorganisms may be disposed on the transfer region. The inoculating member may be configured to transfer the pre-determined quantity of viable microorganisms to a target during an inoculation operation without having to rehydrate the pre-determined quantity of viable microorganisms prior to the inoculating operation.

Abstract: Microbiota restoration therapy (MRT) compositions (e.g., oral MRT compositions) and methods for manufacturing MRT compositions are disclosed. An example method for manufacturing an MRT composition may include collecting a stool sample, purifying the stool sample to form a purified sample, stabilizing the purified sample to form a stabilized sample, converting the stabilized sample to a solid, adding one or more additives and/or excipients to the solid to form a treatment composition, and encapsulating the treatment composition.

Abstract: Microbiota restoration therapy (MRT) compositions (e.g., oral MRT compositions) and methods for manufacturing MRT compositions are disclosed. An example method for manufacturing an MRT composition may include collecting a stool sample, purifying the stool sample to form a purified sample, stabilizing the purified sample to form a stabilized sample, converting the stabilized sample to a solid, adding one or more additives and/or excipients to the solid to form a treatment composition, and encapsulating the treatment composition.

Abstract: Microbiota restoration therapy (MRT) compositions (e.g., oral MRT compositions) and methods for manufacturing MRT compositions are disclosed. An example method for manufacturing an MRT composition may include collecting a stool sample, purifying the stool sample to form a purified sample, stabilizing the purified sample to form a stabilized sample, converting the stabilized sample to a solid, adding one or more additives and/or excipients to the solid to form a treatment composition, and encapsulating the treatment composition.

Abstract: Microbiota restoration therapy (MRT) compositions (e.g., oral MRT compositions) and methods for manufacturing MRT compositions are disclosed. An example method for manufacturing an MRT composition may include collecting a stool sample, purifying the stool sample to form a purified sample, stabilizing the purified sample to form a stabilized sample, converting the stabilized sample to a solid, adding one or more additives and/or excipients to the solid to form a treatment composition, and encapsulating the treatment composition.